Replies to post #105798 on US Stem Cell Inc (USRM)

[NoMoDo]

This was my response a few posts ago.

The underlying question here is who should have regulatory authority over stem cell tissue transplant procedures? The FDA claims to have the legal authority. But if the procedures can be reclassified as tissue manipulation without synthesis then it should be no different than any other tissue transplant procedure.

I think we are in agreement on the basics. You just feel that the FDA's interpretation carries more weight than I do. The FDA itself states clearly that it's guidelines do not bind the public. That, I believe comes from a 2020 law.